微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 63.68% | 7.1% | -3.13% | 42/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 65.73% | -1.19% | 1.65% | 41/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 64.67% | -5.06% | 0.93% | 48/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 64.07% | -10.13% | 7.76% | 50/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 59.46% | -19.62% | -10.62% | 55/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 66.52% | -13.13% | -2.34% | 36/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 68.11% | -13.62% | -4.46% | 35/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 71.29% | -10.63% | -3.62% | 24/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 73.97% | -8.83% | -3.4% | 18/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 76.58% | -5.66% | -2.89% | 13/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 78.86% | -3.65% | -1.15% | 12/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 79.77% | -2.91% | -1.68% | 12/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 81.13% | 2% | -0.05% | 10/131 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 81.17% | -1.44% | -0.82% | 11/131 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 81.85% | 2% | -0.38% | 11/131 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 82.16% | -0.95% | -0.24% | 10/131 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 82.36% | -0.19% | -0.71% | 12/131 | 59.59% | 正海生物 | 91.59% | 行业排名> |
| 2020-06-30 | 82.95% | 2% | 0.52% | 12/131 | 59.94% | 正海生物 | 92.23% | 行业排名> |
| 2019-12-31 | 82.52% | 3.73% | 3.73% | 14/131 | 56.37% | 正海生物 | 92.69% | 行业排名> |
| 2018-12-31 | 79.55% | 7.4% | 7.4% | 17/131 | 55.53% | 正海生物 | 92.61% | 行业排名> |
| 2017-12-31 | 74.06% | 2% | 2% | 23/131 | 55.34% | 正海生物 | 94.38% | 行业排名> |